Form 4: Director Maggiore Sells 20 Shares of Zivo Bioscience, Inc.
SEC Form 4 Filing
Christopher D. Maggiore, a director and 10% owner of Zivo Bioscience, Inc., sold 20 shares of common stock at a price of $16.25 on April 8, 2025.
Summary
- On April 8, 2025, Christopher D. Maggiore, a director and 10% owner of Zivo Bioscience, Inc. (ZIVO), sold 20 shares of the company's common stock.
- The transaction was executed at a price of $16.25 per share.
- Following the transaction, Maggiore directly owns 507,000 shares of ZIVO common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a sale of shares by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about an insider transaction.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions. It provides transparency into the trading activities of company insiders, which can be of interest to investors.
Stakeholder Impact
- The sale of shares by a director could be perceived negatively by some shareholders, but the small number of shares sold is unlikely to have a significant impact.
Key Dates
| Date | Description |
|---|---|
| 04/08/2025 | Date of transaction: Christopher D. Maggiore sold 20 shares of Zivo Bioscience, Inc. common stock. |
| 04/09/2025 | Date of signature for the Form 4 filing. |
Keywords
Zivo Bioscience, ZIVO, Maggiore, Director, Share Sale, Form 4, Beneficial Ownership, Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.